title: A new antiplatelet agent cilostazol--what is the evidence for its use and tolerability?
authors.affiliation: Section of Neurology, Department of Medicine, Aga Khan Hospital, Karachi.
authors.forename: Shaista Anwar
authors.initials: SA
authors.lastname: Sidddiqi
authors.forename: Ayeesha Kamran
authors.initials: AK
authors.lastname: Kamal
mesh_terms: D001241:Aspirin / Q000627:therapeutic use; D000077407:Cilostazol; D019317:Evidence-Based Medicine; D006801:Humans; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use*; D016032:Randomized Controlled Trials as Topic; D020521:Stroke / Q000517:prevention & control*; D013777:Tetrazoles / Q000627:therapeutic use*; D013927:Thrombosis / Q000188:drug therapy*; D016896:Treatment Outcome
chemical_list: D010975:Platelet Aggregation Inhibitors; D013777:Tetrazoles; D000077407:Cilostazol; D001241:Aspirin